LPL Financial
PCVX icon

LPL Financial’s Vaxcyte PCVX Stock Holding History

LPL Financial’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.23M Buy
21,584
+1,509
+8% +$88K ﹤0.01% 4315
2026
Q2 		$1.17M Sell
20,075
-7,249
-27% -$394K ﹤0.01% 4296
2026
Q1 		$1.59M Buy
27,324
+6,835
+33% +$371K ﹤0.01% 3719
2025
Q4 		$945K Buy
20,489
+1,172
+6% +$52.4K ﹤0.01% 4127
2025
Q3 		$696K Buy
19,317
+6,582
+52% +$218K ﹤0.01% 4351
2025
Q2 		$414K Buy
12,735
+3,854
+43% +$126K ﹤0.01% 4532
2025
Q1 		$335K Buy
8,881
+2,318
+35% +$185K ﹤0.01% 4497
2024
Q4 		$537K Sell
6,563
-6,902
-51% -$685K ﹤0.01% 4034
2024
Q3 		$1.54M Buy
13,465
+3,947
+41% +$356K ﹤0.01% 2977
2024
Q2 		$719K Buy
9,518
+956
+11% +$65.1K ﹤0.01% 3553
2024
Q1 		$585K Sell
8,562
-2,202
-20% -$152K ﹤0.01% 3646
2023
Q4 		$676K Buy
10,764
+1,139
+12% +$59.2K ﹤0.01% 3404
2023
Q3 		$491K Buy
9,625
+1,027
+12% +$50.7K ﹤0.01% 3502
2023
Q2 		$429K Buy
+8,598
New +$408K ﹤0.01% 3565

Other funds holding PCVX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial's PCVX Position: Q3 2026 in Review

LPL Financial increased its Vaxcyte (PCVX) stake by 7.5% in Q3 2026, buying an estimated $88K and bringing the position to 21,584 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #4315.

LPL Financial first reported a position in PCVX in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.59M in Q1 2026. 128 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • LPL Financial held 21,584 shares of Vaxcyte worth $1.23M as of Q3 2026.
  • LPL Financial bought 1,509 Vaxcyte shares in Q3 2026, an estimated $88K.
  • Vaxcyte made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #4315 holding.
  • LPL Financial first reported a position in Vaxcyte in Q2 2023 and has held it in 14 quarters since.
  • LPL Financial's Vaxcyte position peaked at $1.59M in Q1 2026.
  • 128 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.